Title: Clinical study of the antiviral effect of Lamivudine in hepatitis B
Abstract: Objective:To observe the therapeutic effect of Lamivudine for chronic hepatitis B. Methods:Among 70 cases chronic hepatitis B patients, 35 cases of patients as treatment group with the Lamivudine treatment, 35 cases of doubleblind, placebo for the control group, treatment time was 60 weeks. Assessment of clinical symptoms and signs, liver function and indicators of HBV replication. Results:There was significant difference in efficacy between Lamivudine group and the control group. Conclusion:The long-term Lamivudine therapy can suppress HBV replication, with the significant improvement in ALT, it is a safe method.
Publication Year: 2010
Publication Date: 2010-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot